Open Access

Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.

Event: ESC Congress 2021 - The Digital Experience
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Sponsored by Daiichi Sankyo Europe GmbH
Date: 30 August 2021
Time: 15:00 - 15:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Welcome and introduction.

Speaker: Doctor S. Saito (Kamakura, JP)
Thumbnail

Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.

Speaker: Professor N. van Mieghem (Rotterdam, NL)
Thumbnail

New developments in NOACs and TAVI: How do we apply them in clinical practice?

Speaker: Professor D. Capodanno (Catania, IT)
Thumbnail

Panel discussion.

Thumbnail

3 speakers from this session

Doctor Shigeru Saito

Shonan Kamakura General Hospital, Kamakura (Japan)
2 presentations
0 follower

Professor Nicolas van Mieghem

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
13 presentations
2 followers

Professor Davide Capodanno

University of Catania, Catania (Italy)
27 presentations
5 followers

Related content

ESC Premium Access

ESC Guidelines 2021 - Pacing and Resynchronisation

4 December 2021

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

This platform is supported by

logo Novo Nordisk